Tendon healing: a concise review on cellular and molecular mechanisms with a particular focus on the Achilles tendon

Tendon is a bradytrophic and hypovascular tissue, hence, healing remains a major challenge. The molecular key events involved in successful repair have to be unravelled to develop nov-el strategies that reduce the risk of unfavourable outcomes such as non-healing, adhesion formation, and scarring. This review will consider the diverse pathophysiological features of tendon-derived cells that lead to failed healing, including misrouted differentiation (e.g. de-or transdifferentiation) and premature cell senescence, as well as the loss of functional progenitors. Many of these features can be attributed to disturbed cell-extracellular matrix (ECM) or unbalanced soluble mediators involving not only resident tendon cells, but also the cross -talk with immigrating immune cell populations. Unrestrained post-traumatic inflam-mation could hinder successful healing. Pro-angiogenic mediators trigger hypervasculariza-tion and lead to persistence of an immature repair tissue, which does not provide sufficient mechano-competence. Tendon repair tissue needs to achieve an ECM composition, structure, strength, and stiffness that resembles the undamaged highly hierarchically ordered tendon ECM. Adequate mechano-sensation and-transduction by tendon cells orchestrate ECM syn-thesis, stabilization by cross-linking, and remodelling as a prerequisite for the adaptation to the increased mechanical challenges during healing. Lastly, this review will discuss, from the cell biological point of view, possible optimization strategies for augmenting Achilles tendon (AT) healing outcomes, including adapted mechanostimulation and novel approaches by restraining neoangiogenesis, modifying stem cell niche parameters, tissue engineering, the modulation of the inflammatory cells, and the application of stimulatory factors.

Automated summary

Tendon healing is a major challenge due to its poor blood supply and slow metabolic rate. The disruption of cell-extracellular matrix interactions and uncontrolled inflammation can hinder successful healing. Optimizing Achilles tendon (AT) healing outcomes may involve adapting mechanical stimulation, restricting neoangiogenesis, and modifying stem cell niche parameters.